Outcomes have improved during the past decade for patients with acute lymphoblastic leukemia who undergo haploidentical hematopoietic cell transplantation.
Researchers sought to determine the effectiveness of venetoclax combinations to improve survival to SCT eligibility in patients with AML as a complication of myeloproliferative neoplasm.
The IDEAL trial found that adolescents and young adults with B-cell acute lymphoblastic leukemia may benefit from restrictive diets and increased exercise.
Researchers sought to determine whether whole-genome sequencing may be a better risk stratification tool compared with conventional cytogenetic analysis.
Researchers sought to determine factors that may impact infection risk in patients with CLL.